trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Osteosarcoma D012516 50 associated lipids
Brain Neoplasms D001932 15 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Federman N et al. Histone acetylation is recruited in consolidation as a molecular feature of stronger memories. 2009 Learn. Mem. pmid:19794185
Sponziello M et al. Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines. 2010 J. Endocrinol. Invest. pmid:19794300
Wu P et al. Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells. 2010 Cell Death Differ. pmid:19798105
Liberatore RA et al. NF-kappaB activity is constitutively elevated in c-Abl null fibroblasts. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19805123
Sasaki K et al. Real-time imaging of histone H4 hyperacetylation in living cells. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19805290
Gibbs A et al. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19805354
Li X et al. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. 2010 Br. J. Haematol. pmid:19807731
Lee JH et al. Notch signal activates hypoxia pathway through HES1-dependent SRC/signal transducers and activators of transcription 3 pathway. 2009 Mol. Cancer Res. pmid:19808903
Hui KF and Chiang AK Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death. 2010 Int. J. Cancer pmid:19816947
Gray SG et al. Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications. 2009 Eur. J. Cancer pmid:19818596
Hara D et al. Persistent BDNF exon I-IX mRNA expression following the withdrawal of neuronal activity in neurons. 2009 Biochem. Biophys. Res. Commun. pmid:19818730
Li C et al. Induction of myelogenous leukemia cells with histone deacetylase inhibitors through down-regulating the Daxx protein expression. 2009 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:19821084
Puca R et al. HIPK2 modulates p53 activity towards pro-apoptotic transcription. 2009 Mol. Cancer pmid:19828042
Röhrs S et al. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia. 2009 Mol. Cancer pmid:19835597
Wang Y et al. HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells. 2009 Neurosci. Lett. pmid:19835929
Di Renzo F et al. VPA-related axial skeletal defects and apoptosis: a proposed event cascade. 2010 Reprod. Toxicol. pmid:19850124
Ai J et al. HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer. 2009 Mol. Endocrinol. pmid:19855091
Meng CF et al. Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells. 2010 Cancer Invest. pmid:19857042
Li X et al. Mta3-NuRD complex is a master regulator for initiation of primitive hematopoiesis in vertebrate embryos. 2009 Blood pmid:19864643
Kusakabe M et al. Impact of DNA demethylation of the G0S2 gene on the transcription of G0S2 in squamous lung cancer cell lines with or without nuclear receptor agonists. 2009 Biochem. Biophys. Res. Commun. pmid:19878646
Krishnan M et al. HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability. 2010 Oncogene pmid:19881542
Ninios YP et al. Histone H1 subtype preferences of DFF40 and possible nuclear localization of DFF40/45 in normal and trichostatin A-treated NB4 leukemic cells. 2010 Apoptosis pmid:19882353
Ma X et al. Identification of LIV1, a putative zinc transporter gene responsible for HDACi-induced apoptosis, using a functional gene screen approach. 2009 Mol. Cancer Ther. pmid:19887557
Dong G et al. Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells. 2010 Am. J. Physiol. Renal Physiol. pmid:19889954
Bhuiyan MM et al. Production of Sei whale (Balaenoptera borealis) cloned embryos by inter- and intra-species somatic cell nuclear transfer. 2010 J. Reprod. Dev. pmid:19893277
Ellis JK et al. Effect of the histone deacetylase inhibitor trichostatin a on the metabolome of cultured primary hepatocytes. 2010 J. Proteome Res. pmid:19894772
Mastitskaya S and Denecke B Human spongiosa mesenchymal stem cells fail to generate cardiomyocytes in vitro. 2009 J Negat Results Biomed pmid:19903342
Marumo T et al. Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. 2010 Am. J. Physiol. Renal Physiol. pmid:19906951
Yakovlev A et al. Epigenetic regulation of caspase-3 gene expression in rat brain development. 2010 Gene pmid:19909801
Patil V et al. Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. 2010 Bioorg. Med. Chem. pmid:19914074
Choi JH et al. TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116. 2010 Biochem. Biophys. Res. Commun. pmid:19914212
Freidkin I et al. Effects of histone deacetylase inhibitors on rat mesangial cells. 2010 Am. J. Physiol. Renal Physiol. pmid:19923417
Perisic T et al. Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. 2010 Neuropsychopharmacology pmid:19924110
Sun F et al. Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells. 2009 Mol. Cancer Ther. pmid:19934278
Koh HS et al. Twist2 regulates CD7 expression and galectin-1-induced apoptosis in mature T-cells. 2009 Mol. Cells pmid:19937140
Host L et al. Cocaine self-administration alters the expression of chromatin-remodelling proteins; modulation by histone deacetylase inhibition. 2011 J. Psychopharmacol. (Oxford) pmid:19939859
Kuribayashi T et al. Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation. 2010 Int. J. Mol. Med. pmid:19956898
Zhang D et al. [Synergistic cytotoxicity effect of histone deacetylase inhibitor combined with paclitaxel on lung cancer cell lines and its mechanism]. 2009 Ai Zheng pmid:19958621
Cao Y et al. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19966229
Hutt DM et al. Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. 2010 Nat. Chem. Biol. pmid:19966789
Aoyama M et al. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. 2010 Nutrition pmid:20004081
von Dassow G et al. Action at a distance during cytokinesis. 2009 J. Cell Biol. pmid:20008563
Wang N and Tilly JL Epigenetic status determines germ cell meiotic commitment in embryonic and postnatal mammalian gonads. 2010 Cell Cycle pmid:20009537
Kakihana M et al. Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition. 2009 J Thorac Oncol pmid:20009910
Wang L et al. Chronic cocaine-induced H3 acetylation and transcriptional activation of CaMKIIalpha in the nucleus accumbens is critical for motivation for drug reinforcement. 2010 Neuropsychopharmacology pmid:20010550
O'Leary DA et al. Identification of small molecule and genetic modulators of AON-induced dystrophin exon skipping by high-throughput screening. 2009 PLoS ONE pmid:20020055
Lee CS et al. Casein kinase 2 inhibition differentially modulates apoptotic effect of trichostatin A against epithelial ovarian carcinoma cell lines. 2010 Mol. Cell. Biochem. pmid:20020183
Ibanez de Caceres I et al. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. 2010 Oncogene pmid:20023704
Huber K et al. Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins). 2010 J. Med. Chem. pmid:20030343
Kroening S et al. Characterization of connective tissue growth factor expression in primary cultures of human tubular epithelial cells: modulation by hypoxia. 2010 Am. J. Physiol. Renal Physiol. pmid:20032117
Benny Klimek ME et al. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. 2010 Biochem. Biophys. Res. Commun. pmid:20036643
Peng CY et al. Growth-inhibiting effects of arsenic trioxide plus epigenetic therapeutic agents on leukemia cell lines. 2010 Leuk. Lymphoma pmid:20038232
Li RJ et al. Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance. 2010 Ann. Oncol. pmid:20038517
Nordén R et al. Inhibition of protein deacetylation augments herpes simplex virus type 1-activated transcription of host fucosyltransferase genes associated with virus-induced sLex expression. 2010 Arch. Virol. pmid:20039087
Sayan BS et al. Induction of TAp63 by histone deacetylase inhibitors. 2010 Biochem. Biophys. Res. Commun. pmid:20043870
Islam NM et al. Bicyclic peptides as potent inhibitors of histone deacetylases: optimization of alkyl loop length. 2010 Bioorg. Med. Chem. Lett. pmid:20045316
Wu J et al. Trichostatin A sensitizes cisplatin-resistant A549 cells to apoptosis by up-regulating death-associated protein kinase. 2010 Acta Pharmacol. Sin. pmid:20048748
Hebbel RP et al. The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice. 2010 Blood pmid:20053759
He R et al. Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agents. 2010 J. Med. Chem. pmid:20055418
Ajiro K et al. Reciprocal epigenetic modification of histone H2B occurs in chromatin during apoptosis in vitro and in vivo. 2010 Cell Death Differ. pmid:20057502
Taura A et al. Histone deacetylase inhibition enhances adenoviral vector transduction in inner ear tissue. 2010 Neuroscience pmid:20060033
Chou JL et al. Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. 2010 Lab. Invest. pmid:20065949
Chang J et al. Hepatopoietin Cn suppresses apoptosis of human hepatocellular carcinoma cells by up-regulating myeloid cell leukemia-1. 2010 World J. Gastroenterol. pmid:20066738
Choi YS et al. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. 2010 J. Cell. Mol. Med. pmid:20070436
Lee KJ et al. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. 2010 Biochim. Biophys. Acta pmid:20080132
Bracha AL et al. Carbon metabolism-mediated myogenic differentiation. 2010 Nat. Chem. Biol. pmid:20081855
Pan L et al. Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A /sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation. 2010 FEBS J. pmid:20089040
Wang J et al. Effect of EGF-induced HDAC6 activation on corneal epithelial wound healing. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20089874
Nunes MJ et al. Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription. 2010 J. Neurochem. pmid:20096088
Aizawa S and Yamamuro Y Involvement of histone acetylation in the regulation of choline acetyltransferase gene in NG108-15 neuronal cells. 2010 Neurochem. Int. pmid:20100532
Grabiec AM et al. Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. 2010 J. Immunol. pmid:20100935
Chatterjee A et al. An efficient synthesis of (+/-)-trichostatic Acid and analogues: a new route to (+/-)-trichostatin A. 2010 Org. Lett. pmid:20104892
Kicic A et al. Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium. 2010 Am. J. Respir. Crit. Care Med. pmid:20110557
Liang Q et al. The novel human endogenous retrovirus-related gene, psiTPTE22-HERV, is silenced by DNA methylation in cancers. 2010 Int. J. Cancer pmid:20112338
Beedanagari SR et al. Differential regulation of the dioxin-induced Cyp1a1 and Cyp1b1 genes in mouse hepatoma and fibroblast cell lines. 2010 Toxicol. Lett. pmid:20116417
Lu Y et al. Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. 2010 Hum. Reprod. pmid:20118114
Izawa M et al. Inhibition of histone deacetylase causes reduction of appressorium formation in the rice blast fungus Magnaporthe oryzae. 2009 J. Gen. Appl. Microbiol. pmid:20118613
Hajji N et al. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide. 2010 Oncogene pmid:20118981
Wu Y et al. Constitutive and tumor necrosis factor-alpha-stimulated activation of nuclear factor-kappaB in immortalized endometriotic cells and their suppression by trichostatin A. 2010 Gynecol. Obstet. Invest. pmid:20130413
Zhao J et al. Histone deacetylase inhibitors improve in vitro and in vivo developmental competence of somatic cell nuclear transfer porcine embryos. 2010 Cell Reprogram pmid:20132015
Martinez-Diaz MA et al. Pre- and postimplantation development of swine-cloned embryos derived from fibroblasts and bone marrow cells after inhibition of histone deacetylases. 2010 Cell Reprogram pmid:20132016
Host L et al. Inhibition of histone deacetylases in rats self-administering cocaine regulates lissencephaly gene-1 and reelin gene expression, as revealed by microarray technique. 2010 J. Neurochem. pmid:20132486
Wu Y et al. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. 2010 BMC Cancer pmid:20132554
Mercer TR et al. Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. 2010 BMC Neurosci pmid:20137068
Hodges SJ et al. The effect of epigenetic therapy on congenital neurogenic bladders--a pilot study. 2010 Urology pmid:20138341
Bradner JE et al. Chemical phylogenetics of histone deacetylases. 2010 Nat. Chem. Biol. pmid:20139990
Okada T et al. TWIST1 hypermethylation is observed frequently in colorectal tumors and its overexpression is associated with unfavorable outcomes in patients with colorectal cancer. 2010 Genes Chromosomes Cancer pmid:20140954
Wessels I et al. Changes in chromatin structure and methylation of the human interleukin-1beta gene during monopoiesis. 2010 Immunology pmid:20141541
Swingler TE et al. MMP28 gene expression is regulated by Sp1 transcription factor acetylation. 2010 Biochem. J. pmid:20144149
Liu TY et al. EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis. 2010 Mol. Cancer pmid:20144199
Suh HS et al. Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes. 2010 J Neuroimmune Pharmacol pmid:20157787
Crosson CE et al. Inhibition of histone deacetylase protects the retina from ischemic injury. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20164449
Jang ER et al. ATM modulates transcription in response to histone deacetylase inhibition as part of its DNA damage response. 2010 Exp. Mol. Med. pmid:20164679
Desai D et al. SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors. 2010 Bioorg. Med. Chem. Lett. pmid:20167479
Awe S and Renkawitz-Pohl R Histone H4 acetylation is essential to proceed from a histone- to a protamine-based chromatin structure in spermatid nuclei of Drosophila melanogaster. 2010 Syst Biol Reprod Med pmid:20170286
Akiba Y et al. Histone deacetylase inhibitors de-repress tyrosine hydroxylase expression in the olfactory bulb and rostral migratory stream. 2010 Biochem. Biophys. Res. Commun. pmid:20170631
Angst E et al. Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells. 2010 Pancreas pmid:20173668
Zhang L et al. Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis. 2010 World J Surg pmid:20177680
Fakhry H et al. Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells. 2010 Hum. Pathol. pmid:20178884
Wood JP et al. A comparison of differentiation protocols for RGC-5 cells. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20181845